论文部分内容阅读
选择我院2012年4月~2014年4月收治的120例帕金森患者为研究对象,随机分为对照组和观察组各60例,对照组单用多巴丝肼治疗,观察组行多巴丝肼与小剂量多奈哌齐治疗,对两组患者治疗后认知功能与抑郁情绪改善情况分析。观察组治疗后总有效率为96.67%,对照组为70.00%,差异有统计学意义(P<0.05);两组患者治疗前认知功能、抑郁情绪评分显示无明显差异(P>0.05),经治疗后,观察组评分明显优于对照组,差异有统计学意义(P<0.05)。采取多巴丝肼与小剂量多奈哌齐治疗帕金森病,能显著改善患者认知功能与抑郁情绪,利于患者远期预后,值得临床进一步推广使用。
We selected 120 patients with Parkinson’s disease admitted to our hospital from April 2012 to April 2014 as study subjects and were randomly divided into control group and observation group of 60 cases each. The control group was treated with dopplerizide alone. The observation group was treated with dopa Silkworm and small doses of donepezil treatment, the improvement of cognitive function and depression in two groups of patients after treatment analysis. The total effective rate was 96.67% in the observation group and 70.00% in the control group, the difference was statistically significant (P <0.05). There was no significant difference between the two groups in the scores of cognitive function and depression before treatment (P> 0.05) After treatment, the observation group score was significantly better than the control group, the difference was statistically significant (P <0.05). To take doppler hydrazide and small doses of donepezil in the treatment of Parkinson’s disease, can significantly improve the patient’s cognitive function and depression, which is conducive to the long-term prognosis of patients, it is worth further clinical use.